America October 24, 2025
Eli Lilly to Acquire Adverum Biotechnologies
Pharmaceutical powerhouse Eli Lilly and Co. announced Friday that it will acquire Adverum Biotechnologies, a clinical-stage gene therapy innovator targeting…
America January 30, 2025
MaxCyte Buys SeQure Dx for Up to $7M
MaxCyte Inc., a leading cell therapy and gene editing company, announced Thursday that it has acquired SeQure Dx, a specialized…
America March 29, 2024
Biotech Co. Inflated Gene Therapy Prospects
A proposed class action lawsuit filed Thursday in a Massachusetts district court accuses Massachusetts-based biotechnology company Bluebird Bio Inc. of…
America November 3, 2023
Paul Hastings Manages IPO for Lexeo Therapeutics: A Genetic Medicine Game-Changer
In a heart-pounding financial feat, Lexeo Therapeutics Inc., a trailblazing gene-therapy focused biotechnology firm, has unleashed a torrent of excitement…
FOLLOW US
Recent Posts
Arizona
January 11, 2025
Kelly Warner Law Firm Blames USA Herald for Arizona Bar Investigation
Arizona
December 12, 2024
Arizona Bar Opens Investigation on Attorney Aaron Kelly
America
March 16, 2026
Gregory Bovino Retirement Ends Controversial Border Patrol Career
America
March 16, 2026
New Molten Planet Identified, Revealing Possible New Class of Alien Worlds
America
March 16, 2026
Bank of America Epstein Survivors’ Lawsuit Settlement Reached in High-Profile Abuse Case
America
March 16, 2026
Wiles Announces Cancer Diagnosis as White House Chief of Staff Continues Duties
America
March 16, 2026